Ludmila Martin is an Oncology physician. OpenAlex indexes 45 publications with 573 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1624 S I St
Suite 305
Tacoma, WA 984055016
Telephone
253-428-8700Registry record last updated 4 Nov 2014.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20253 payments
- Iovance Biotherapeutics, Inc.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.3%Platinum-based Drug17.2%Oxaliplatin98%Carboplatin2%Part B, office-administered≥17 patientsPD-1 inhibitor12.8%Pembrolizumab100%Part B, office-administered≥22 patients+ 10 more classes in this area
Metabolism & gastrointestinal
33.6%Other antiemetics30%Fosaprepitant100%Part B, office-administered≥54 patientsSerotonin-3 Receptor Antagonist2.7%Palonosetron hcl77%Ondansetron hydrochloride20%Ondansetron Odt2%Part D + Part B≥58 patients+ 10 more classes in this area
Blood & clotting
8.5%Erythropoiesis-stimulating Agent8.4%Darbepoetin alfa100%Part B, office-administered≥14 patientsFactor Xa inhibitor0.1%Eliquis56%Xarelto44%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”